Fortis Healthcare, through its wholly-owned subsidiary International Hospital Ltd. (IHL), has signed a 15-year lease agreement with RR Lifesciences to operate and expand Fortis Hospital Greater Noida, strengthening its presence in the Delhi-NCR region.
Previously managed under an Operations & Management (O&M) arrangement since October 2022, the 200-bed multi-specialty hospital now comes under Fortis’s full operational and financial control. The facility, built on a 1.35-acre UPSIDA-leased plot with a 2.7 lakh sq. ft. built-up area, offers expansion potential of up to 250 beds.
Commenting on the development, Dr. Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare, said:
“The addition of Fortis Hospital Greater Noida underlines our commitment to strengthening healthcare delivery across NCR. Our focus will remain on delivering high-quality, ethical, and patient-centric care.”
The move is expected to further reinforce Greater Noida’s emergence as a key healthcare hub within the region.
News by Rahul Yelligetti.